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Abstract
At the beginning of the 21st century cancer research has reached an impasse similar to that experienced in
developmental biology in the first decades of the 20th century when conflicting results and interpretations co-
existed for a long time until these differences were resolved and contradictions were eliminated. In cancer
research, instead of this healthy “weeding-out” process, there have been attempts to reach a premature synthesis,
while no hypothesis is being rejected. Systems Biology could help cancer research to overcome this stalemate by
resolving contradictions and identifying spurious data. First, in silico experiments should allow cancer researchers to
be bold and a priori reject sets of data and hypotheses in order to gain a deeper understanding of how each
dataset and each hypothesis contributes to the overall picture. In turn, this process should generate novel
hypotheses and rules, which could be explored using these in silico approaches. These activities are significantly
less costly and much faster than “wet-experiments”. Consequently, Systems Biology could be advantageously used
both as a heuristic tool to guide “wet-experiments” and to refine hypotheses and test predictions.
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The history of science shows that knowledge is acquired
through the competition among alternative theories. Only
after these theories are thoroughly explored, its compo-
nents tested and validated, opportunity for a synthesis may
arise. At such a time, contradictions may be resolved and
both spurious “facts” and wrong premises can be recog-
nized and dismissed. A misguided, premature synthesis
may, instead, lead to an “anything goes” attitude where
any given interpretation and its opposite happily coexist,
incoherence is accepted as being the inexorable conse-
quence of dealing with complexity. In such an instance,
everything is explained because if results do not fit one
theory, they may fit its opposite or an ad hoc alternative
one. As room is made to reconcile every improper fit,
there is no chance to rule out any of them. This attitude
subverts the objectives of science as described by Ayala,
namely: “First, science seeks to organize knowledge in a
systematic way by exhibiting patterns of relations among
statements concerning facts which may not appear
obviously as mutually related... It is the second distinctive
characteristic of science that it strives to provide
explanations of why the observed events do in fact occur.
Science attempts to discover and to formulate the condi-
tions under which the observed facts and their mutual
relationships exist. Thirdly, the explanatory hypotheses
provided by science must be genuinely testable, and there-
fore subject to the possibility of rejection [1].”
An example of such a premature synthesis of opposing
hypotheses in the biological sciences took place about a
century ago. Jane Maienschein [2] quoted embryologist
Herbert S. Jennings who when assessing the state of
embryology recalled that different embryologists did
similar experiments and arrived at quite different con-
clusions. “All the conflicting reports were correct. The
situation was that of the Gilbertian comic opera chorus,
‘For you are right, and I am right, and he is right and all
is right’”. Maienschein’s analysis implied that epistemol-
ogy does matter, and that competition between or
among hypotheses is indeed fruitful.
The experiments done by Wilhelm Roux and Hans
Driesch on the developmental potential of blastomeres
probably are the best illustration of the above-referred
situation. Roux believed that differentiation was driven by
a mosaic pattern of development, in which the generation
of phenotypic diversity resulted from unequal segregation
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geny, as was previously proposed by August Weismann.
Roux’s experimental approach to explore this process was
to destroy one of the two blastomeres resulting from the
first cleavage, and the result of this intervention was a
“half-embryo” as he predicted. Driesch expected to find
similar results, but his experimental approach instead
entailed the separation of the blastomeres. The resulting
embryos were normal but smaller. He discovered “regula-
tive” development, whereby a single blastomere was able
to generate a whole embryo. He abandoned Roux’s
hypothesis in light of these results. Roux stuck to his
interpretation on the grounds that his theory explained
many facts, and to justify Driesch’s results he proposed
the ad hoc explanation that a “reserve germ plasm”
existed in the blastomeres. Parenthetically, Roux used
frog and Driesch used sea urchin embryos; both undergo
regulative development as first shown by Driesch. The
impasse was resolved when embryologists concluded that,
during the first and second cleavages, embryonic develop-
ment could undergo either a regulated or a mosaic pat-
tern of development, the first giving occasionally identical
twins; however, any given species undergoes only one of
the two. This historical example shows that it is indeed
difficult, if not impossible, to advance knowledge without
a clear epistemology to guide experimental design, data
gathering, and their interpretation into evidence for or
against a given hypothesis.
Parenthetically, it was the American embryologist
Edmund B. Wilson who even-mindedly proposed that
regulative and mosaic development were the extremes
of a gradient [3]. This perspective is now prevalent
because at specific times during development, a given
cell may behave as a mosaic, its fate being specified by
its history, and at the next stage its fate is specified by
its locale, i.e., its neighbors. This, and similar findings
prompted Lawrence and Levine to state: “It is time to
move on and donate mosaic and regulative development
to the archives” [4]. However, the fact remains that if
one defines regulated and mosaic in terms of the first
and second cleavage, regulated embryos do exist, and
they explain the occurrence of identical twins.
Cancer theories and their impact on the
comprehensibility of the disease
Cancer research has been undergoing a comparable type
of epistemological crisis for the last forty years, a far too
long stretch given the societal impact of the disease.
Until Theodor Boveri’s proposal of the precursor of the
somatic mutation theory in 1914, cancer was considered
a tissue-based problem akin to altered embryonic devel-
opment [5,6]. Boveri’s proposal that cancer was caused,
instead, by alterations of the genetic material shifted the
cancer problem from the relational, tissue-based one, to
an autonomous phenomenon occurring inside a cell.
The philosopher and historian Lenny Moss identified a
change of perception in the twentieth century that led
to the “phylogenetic turn” whereby “... the gene and the
genetic program became understood to be the principal
means by which adapted form is acquired; the theater of
adaptation changed from that of individual life histories,
that is ontogenies, to that of populations over multiple
generations, that is phylogenies” [7]. During the last dec-
ades of the 20
th century until now, biologists focused on
the cell’s interior and the somatic mutation theory
became the dominant view in carcinogenesis. From this
perspective, cancer became a disease caused by muta-
tions in the DNA of a single founder cell; the tissue-
based view did not disappear completely but was mostly
disregarded by the mainstream.
Until the advent of the oncogene theory in the 1970s,
there were multiple competing theories to explain can-
cer that differed at the level of biological organization
in which carcinogenesis occurred. Thus, discussions
centered on whether cancer was either a problem of
control of cell proliferation and/or of cell differentia-
tion, or of tissue organization [8]. Clyde Dawe [9], J.W.
Orr [10], Beatrice Mintz [11], G. Barry Pierce [12], and
others offered compelling evidence for carcinogenesis
to be considered as a tissue-based phenomenon akin to
development gone awry. Notwithstanding, around the
1960s and 70s a narrow reductionist view based on in
vitro transformation assays as a model for neoplasia
became dominant, replacing for the most part the ani-
mal models that were used until then. Philosophers,
historians, and sociologists of biology have advanced
explanations about how this view achieved dominance.
One of them, Joan Fujimura, proposed a sociological
explanation that connected the interests of molecular
biologists and the rise of the genetic engineering bio-
technology industry into constructing “doable pro-
blems” such as “Are there molecular changes in the
cellular proto-oncogenes of tumor cells?” [13]. Michel
Morange proposed, instead, an epistemic explanation
implying that the oncogene theory became attractive to
researchers because it suggested a straight-forward
research program. Within this narrow context, the pro-
ducts of oncogenes participated in signal transduction
conveying messages from the extracellular milieu
through membrane receptors to the nucleus and these
messages regulated cell division and proliferation.
However, when proto-oncogenes were found in yeast,
the carcinogenesis hypotheses that favored develop-
ment and differentiation as central to the neoplastic
process were challenged [14]. Finally, Ton van Hel-
voort, suggested that the oncogene theory linked exo-
genous (environmental) and endogenous (genetic)
explanations of cancer in a single paradigm [15].
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ory, hundreds of oncogenes [16] and dozens of suppres-
sor genes [17] have been described. It is therefore
reasonable to concur with the assessment by William C.
Hahn and Robert A. Weinberg that, “For those who
believe in the simplification and rationalization of the
cancer process, the actual course of research on the
molecular basis of cancer has been largely disappointing.
Rather than revealing a small number of genetic and
biochemical determinants operating within cancer cells,
molecular analyses of human cancers have revealed a
bewilderingly complex array of such factors” [18]. This
assertion is in direct contradiction with the expectations
that gave rise to the concept of oncogenes, which
acquired their name because of their presumed “domi-
nant” behavior; that is, at first, only one of them was
expected to achieve the expression of a “transformed”
phenotype, as suggested by experiments using Rous sar-
coma viruses and primary cultures of chicken cells.
As inconsistencies grew, the number of oncogenes
increased.
A subsequent revised version of the oncogene theory,
according to Hahn and Weinberg, proposed “... that the
pathogenesis of human cancers is governed by a set of
genetic and biochemical rules that apply to most and
perhaps all types of human tumors. We believe that the
identities of the mutant genes in human tumor cells will
one day be conceptualized in terms of these underlying
rules.” The proposal was thus, to “... outline the basic
rules governing the neoplastic transformation of normal
human cells”. According to Hahn and Weinberg, one
had to look at certain properties of cancer cells such as
“... to generate their own mitogenic signals, to resist
exogenous growth-inhibitory signals, to evade apoptosis,
to proliferate without limits (i.e., to undergo immortali-
zation), to acquire vasculature (i.e., to undergo angio-
genesis), and in more advanced cancers, to invade and
metastasize.”[18] Central to this revised view as well as
to the original one, dubbed as “the hallmarks of cancer”
was the idea that carcinogenesis is a cell-based problem
due to mutations that cause the founder cancer cell and
its progeny to “proliferate without limits”.
The search for unifying rules was thwarted by conflict-
ing reports from within the oncogene paradigm.
Namely, “Oncogenes and tumor suppressor genes are
important not only for cell proliferation but also for cell
fate determination (differentiation, senescence, and
apoptosis), their effects often depending on the type of
cell in which they are expressed. Thus, overexpression
of a given oncogene can enhance growth in one cell
type but inhibit growth or induce apoptosis in another”
[19]. Hence, as stated above, when data did not fit the
oncogene theory, ad hoc explanations were proposed
[20]. These interpretations of convenience lead to a
situation whereby any possible conclusion was accepted
as valid, because no alternative concept was ever dis-
proved. Rather, a new layer of complexity was added. If
something did not work as expected, it was blamed on
its particular context and the unfathomable complexity
of cancer. In sum, something could be anything and its
opposite.
Admittedly, while the oncogene theory became domi-
nant, much was learned about the role of cell-cell, tis-
sue-tissue, and cell-extracellular matrix interactions in
morphogenesis during development [6]. Meanwhile, in
the last decade, the application of the morphogenetic
field concept to cancer research revealed that when car-
cinogen exposed stroma was recombined with normal
unexposed epithelial cells the latter underwent carcino-
genesis [21,22]. Conversely, a neoplastic phenotype was
reversed when cells from a neoplasia were placed in a
normal environment [23,24]. Thus, interactions among
cells in a tissue determine normal and neoplastic beha-
vior, and imply that the neoplastic phenotype is reversi-
ble. However, in the current pervasive “anything goes”
atmosphere, the findings of the alternative tissue-based
theory, namely, the tissue organization field theory, are
also being incorporated into the oncogene theory, like
in “... incipient neoplasias begin the interplay by recruit-
ing and activating stromal cell types that assemble into
an initial preneoplastic stroma, which in turn responds
reciprocally by enhancing the neoplastic phenotypes of
the nearby cancer cells [25].” Hence, for those who are
committed to explain carcinogenesis through a sub-cel-
lular (mutational) strategy, the causal role of the stroma
in carcinogenesis is transformed into the problem of
how mutated genes affect the interactions of the cancer
cells harboring these genes with otherwise normal
neighboring cells. This is another example of a prema-
ture synthesis we were referring to above.
Another example of this premature synthesis is pro-
vided by the interpretation of experiments conducted in
a surrogate 3D culture model. On the one hand, the
authors state that “The outgrowth of sporadic mutant
cells within tightly regulated cellular environments is
fundamental to tumour evolution... “ while on the other,
they acknowledge that mutations are not sufficient to
predict neoplastic behavior. By simultaneously embra-
cing both hypotheses (the somatic mutation theory and
the tissue organization field theory), a normal phenom-
enon during development, i.e., the capacity of an epithe-
lium to extrude cells, is re-interpreted within a
carcinogenesis context: “... a cell translocation mechan-
ism allows sporadic mutant cells to evade suppressive
micro-environments and elicits clonal selection for sur-
vival and proliferative expansion outside the native
niches of these cells.” Again, if carcinogenesis is a cell-
intrinsic problem where mutations in oncogenes
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into this theory an inhibitory role by the neighboring
tissue. Moreover, not all the oncogenes investigated had
this effect, and the translocation effect seems to be
related instead to cell-to-cell and cell-to-matrix adhesion
and to the effect of metalloproteases [26]. In experi-
ments also performed in a surrogate 3D culture model,
it was shown once more that at the single-cell level, “a
cancer cell” and a normal cell behave similarly [27], thus
confirming that no alleged qualitative differences exist
between a normal cell and a tumor-derived (mutated)
cell. The qualitative different properties between nor-
mality and carcinogenesis become patent at the tissue-
level of biological complexity. That is, single cells
belonging to a tumor mass retain the fundamental quali-
tative behavioral properties of normal cells, i.e., prolif-
eration and motility [6,20,28].
As noted at the beginning of this Commentary, choos-
ing between competing premises and testing hypothesis
have been central components of experimental science
since its inception during the Renaissance. Only after a
rigorous weeding-out process, will a synthesis among
different theories be justified. One of the main reasons
for the reticence of researchers to deal with contradic-
tions within the somatic mutation theory lies in the
massive cost in time and resources needed to attack
them experimentally, and the uncertainty that such
effort may, after all, not bring about the anticipated
results. Indeed, this feared outcome may also have dele-
terious consequences career-wise. Thus, experimental
biologists are justifiably concerned when answering the
relevant questions..., how and by whom can these pro-
blems be objectively judged and addressed?
Systems Biology to the rescue?
The shortcomings of the somatic mutation theory both
to explain carcinogenesis and to be translated into an
effective therapeutic strategy are now being recognized
even by those who side with it [29]. The reemergence of
Systems Biology offers an opportunity to overcome the
impasse. At present, there are various currents among
its practitioners. O’Malley and Dupre [30] call the
genetic approach ‘pragmatic systems biology,’ which is
centered around large-scale molecular interactions, such
as gene networks, while the organicist approach, called
‘systems-theoretic biology’, is centered on system princi-
ples. The differences between both approaches are not
technical but rather philosophical, given that both are
committed to mathematical modeling. The former uses
bottom-up reductionistic approaches, the latter uses
more “organicist” approaches that take into considera-
tion bottom-up and top-down causality [31-33]. The
tools of mathematical modeling and computer simula-
tion, guided by a sound epistemological foundation,
have the potential of providing the means to address the
widening intellectual vacuum both theoretically and
pragmatically. We hasten to add that a “sound episte-
mological foundation” is central to the usefulness of the
outcome. Whenever the physical, tri-dimensional nature
of organisms and their organs and tissues is being con-
sidered, and the very nature of life as a process is
acknowledged, we have in fact, made important deci-
sions about which type of Systems Biology we are
adopting. Mathematical modeling and computer simula-
tion enables researchers the boldness to choose premises
and temporarily reject data sets without having to com-
mit prematurely to a program of expensive and time-
consuming ‘wet’ experiments. This exploratory role of
Systems Biology may become central to breaking the
h a b i to ff i x i n gl a c k so ff i tw i t had hoc explanations
instead of taking a bold and critical look at the premises
that were adopted [32,34]. The generation of counterin-
tuitive in silico results may inspire new ‘wet’ research
for both model validation and hypothesis testing. In fact,
this is already happening as shown by a challenge to the
widely accepted “hallmarks of cancer” that assumes that
cancer cells actively evade cell death [35].
Returning to Driesch and Roux, we now know that,
regarding the first and second cleavages, on the one
hand, vertebrate development is regulated and that, on
the other, in some invertebrate species development is
mosaic, but any given organism expresses only one of
these two modes. In this context, cancer research should
benefit from rejoining the long and successful tradition
in the exact sciences and in the biology of yore of dis-
carding premises and falsifying hypotheses. And yes,
cancer research in particular and biology at large should
welcome the Systems Biology approach, originally out-
lined by Paul Weiss and Ludwig von Bertalanffy [36,37]
who envisioned the advantages of adopting an organicist
approach to the understanding of the living [38,39]. A
new methodological outlook where mathematicians will
join biologists in having an active participation in the
design, exploration and interpretation of these subjects
seems now necessary and timely. Simultaneously, the
merging of this complementary expertise may have the
added advantage of bringing into cancer biology a tradi-
tion whereby theories “... must be genuinely testable,
and therefore subject to the possibility of rejection.”
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